Robin Ali, PhD, and other international researchers received the Champalimaud Vision Award from left to right: Albert M. Maguire, MD Jean Bennett, MD, PhD Samuel G. Jacobson, MD, PhD Michael Redmond, PhD James Bainbridge MD, PhD Robin Ali, PhD
Recipients of the 2018 Champalimaud Vision Award Include Dr. Robin Ali, PhD
groundbreaking trials demonstrating the safety and efficacy of gene therapies for patients with inherited eye diseases. His collaboration with researchers at Kellogg greatly strengthens our translational research program.
Launched in 2006, the Antonio Champalimaud Vision
Robin Ali, PhD, F.Med.Sci., Visiting Professor at the Kellogg
Award alternates yearly between honoring major scientific
Eye Center, is one of seven scientists to share the 2018
breakthroughs in the understanding or preservation of vision
Champalimaud Vision Award.
(the focus in 2018) and outstanding contributions to the
alleviation of vision impairment and blindness, primarily in
Two independent international teams, from the University
of Pennsylvania and from the University College London, were
developing countries. With a prize of one million Euros, it is
recognized for developing a gene therapy treatment for patients
the largest vision award in the world.
with Leber Congenital Amaurosis, a genetic condition that leads
to childhood blindness. The advancement is the first successful
us achieve our mission,” says Kellogg Director Paul Lee, MD,
gene therapy for any inherited human disease.
JD. “We’re so fortunate to partner with Dr. Ali and his team.
We congratulate the two teams on this recognition of their
At his primary appointment as Professor of Human
Molecular Genetics, University College London Institute of
At the 2018 Association of University Professors of Ophthalmology Research to Prevent Blindness resident and fellow research forum, former resident and current retina fellow Thomas Wubben, MD, PhD, and former resident and current faculty Nakul Shekawat, MD, were honored as invited speakers. Dr. Shekhawat also received an American Society of Cataract and Refractive Surgery (ASCRS) Foundation Resident Excellence Award.
22
Ophthalmology & Institute of Child Health, Dr. Ali has led
“Working with some of the world’s best and brightest helps
game-changing research.”